Launch Pad

Share

Special Episode! Venture Lab 2021 Startup Challenge

Venture Lab is hosting their 2021 Startup Challenge, sponsored by Eric Aroesty, on Friday, April 30th and Karl interviews five semi-finalists from challenge in this hour long special episode! 


  • Nouri -- For expecting families with pregnancy challenges (e.g. conceiving, symptoms, recovery), Nouri provides an Eastern food therapy meets Western nutrition meal plan to help moms feel better at each stage. While meal plans are our first product, we plan to expand on our Eastern therapy philosophy to become the holistic health “one-stop-shop” for life’s most critical stages. Irene Liu, WG22 & Jennifer Doro


  • Xoma -- the first social impact distilled pulque agave brand to enter the US marketplace. It is the smoother tasting, more sophisticated cousin of mezcal and tequila that’s sustainable and generates social impact. Anthony Morano, G21, WG21 Iacopo Santini, W15, G21, WG21


  • Fulton (formally known as Atlas) -- a brand that is modernizing arch support, and is starting by developing an orthopedic insole that is comfortable, supportive, and custom-tailored to the individual wearer. Fulton aims to build a relatable brand that connects with consumers and educates them on the relationship between arch support and overall wellness. Libie Motchan, WG21 Daniel Nelson, WG21


  • 3Cor Bio has developed a low-cost, rapid, and highly accurate diagnostic platform targeting multiple infectious diseases. The COVID-19 pandemic has shown the urgent need for a device that can offer accurate, inexpensive, and rapid diagnosis. Our platform provides a COVID diagnosis within 4 minutes with 97% accuracy for $4.67 per test. Ranjan Pati, C21, W21


  • Altrui Rx  is a non-profit venture that facilitates the redistribution of unused short-dated medications to those in need by acting as a conduit between pharmaceutical manufacturers and charitable organizations. We work with our partners to facilitate the distribution of essential medications to victims in disaster areas, uninsured patients in the US, and underserved communities across the world. Within just a few months, Altrui Rx has facilitated the redirection of over 45 million units of medications—worth over $19 million—to patients in need. Sourish Jasti W24; Justin Zhang, ENG’24; Joe Kakkis, C’21; Shreya Kavuru; Rahul Kavuru